☰

Mobin A. Karimi, Ph.D. - Publications

Affiliations: 
2012 Animal Science University of Massachusetts, Amherst, Amherst, MA 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mammadli M, Suo L, Sen JM, Karimi M. TCF-1 Is Required for CD4 T Cell Persistence Functions during AlloImmunity. International Journal of Molecular Sciences. 24. PMID 36901757 DOI: 10.3390/ijms24054326  0.421
2023 Mammadli M, Suo L, Sen JM, Karimi M. TCF-1 negatively regulates the suppressive ability of canonical and non-canonical Tregs. Journal of Leukocyte Biology. PMID 36806938 DOI: 10.1093/jleuko/qiad019  0.38
2022 Harris R, Mammadli M, Hiner S, Suo L, Yang Q, Sen JM, Karimi M. TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses. Cancer Immunology, Immunotherapy : Cii. PMID 36562825 DOI: 10.1007/s00262-022-03323-0  0.45
2022 Mammadli M, Harris R, Suo L, May A, Gentile T, Waickman AT, Bah A, August A, Nurmemmedov E, Karimi M. Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells. Clinical and Translational Medicine. 11: e625. PMID 34919342 DOI: 10.1002/ctm2.625  0.427
2021 Mammadli M, Harris R, Mahmudlu S, Verma A, May A, Dhawan R, Waickman AT, Sen JM, August A, Karimi M. Human Wnt/β-Catenin Regulates Alloimmune Signaling during Allogeneic Transplantation. Cancers. 13. PMID 34359702 DOI: 10.3390/cancers13153798  0.408
2021 Mammadli M, Huang W, Harris R, Xiong H, Weeks S, May A, Gentile T, Henty-Ridilla J, Waickman AT, August A, Bah A, Karimi M. Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCT. Iscience. 24: 102286. PMID 33851101 DOI: 10.1016/j.isci.2021.102286  0.426
2020 Mammadli M, Huang W, Harris R, Sultana A, Cheng Y, Tong W, Pu J, Gentile T, Dsouza S, Yang Q, Bah A, August A, Karimi M. Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT. Frontiers in Immunology. 11: 593863. PMID 33324410 DOI: 10.3389/fimmu.2020.593863  0.432
2020 Roy NH, Mammadli M, Burkhardt JK, Karimi M. CrkL is required for donor T cell migration to GvHD target organs. Oncotarget. 11: 1505-1514. PMID 32391120 DOI: 10.18632/Oncotarget.27509  0.404
2019 Roy NH, MacKay JL, Buffone A, Newell K, Robertson TF, Agarwal S, Karimi M, Hammer DA, Burkhardt JK. Abstract B183: LFA-1 signals via Crk adapter proteins to induce actin-dependent T-cell migration and mechanosensing Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B183  0.454
2015 Karimi MA, Bryson JL, Richman LP, Fesnak AD, Leichner TM, Satake A, Vonderheide RH, Raulet DH, Reshef R, Kambayashi T. NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT. Blood. 125: 3655-63. PMID 25788701 DOI: 10.1182/Blood-2015-02-629006  0.517
2015 Huang Y, Clarke F, Karimi M, Roy NH, Williamson EK, Okumura M, Mochizuki K, Chen EJ, Park TJ, Debes GF, Zhang Y, Curran T, Kambayashi T, Burkhardt JK. CRK proteins selectively regulate T cell migration into inflamed tissues. The Journal of Clinical Investigation. 125: 1019-32. PMID 25621495 DOI: 10.1172/Jci77278  0.445
2014 Karimi MA, Aguilar OA, Zou B, Bachmann MH, Carlyle JR, Baldwin CL, Kambayashi T. A truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function. Journal of Immunology (Baltimore, Md. : 1950). 193: 2764-71. PMID 25092887 DOI: 10.4049/Jimmunol.1400920  0.596
2014 Karimi MA, Lee E, Bachmann MH, Salicioni AM, Behrens EM, Kambayashi T, Baldwin CL. Measuring cytotoxicity by bioluminescence imaging outperforms the standard chromium-51 release assay. Plos One. 9: e89357. PMID 24586714 DOI: 10.1371/Journal.Pone.0089357  0.557
2014 Karimi M, Jordon M, Kambayashi T. Separation of Gvhd from GVL Responses By Modulation of TCR Signaling Blood. 124: 3822-3822. DOI: 10.1182/Blood.V124.21.3822.3822  0.51
2013 Karimi M, Leichner TM, Satake A, Raulet D, Kambayashi T. Transient NKG2D Blockade Attenuates Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effects Blood. 122: 3242-3242. DOI: 10.1182/Blood.V122.21.3242.3242  0.546
2009 Abrahamsson AE, Geron I, Gotlib J, Dao KH, Barroga CF, Newton IG, Giles FJ, Durocher J, Creusot RS, Karimi M, Jones C, Zehnder JL, Keating A, Negrin RS, Weissman IL, et al. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Proceedings of the National Academy of Sciences of the United States of America. 106: 3925-9. PMID 19237556 DOI: 10.1073/Pnas.0900189106  0.326
2008 Nishimura R, Baker J, Beilhack A, Zeiser R, Olson JA, Sega EI, Karimi M, Negrin RS. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity. Blood. 112: 2563-74. PMID 18565854 DOI: 10.1182/Blood-2007-06-092817  0.522
2007 Duda J, Karimi M, Negrin RS, Contag CH. Methods for imaging cell fates in hematopoiesis. Methods in Molecular Medicine. 134: 17-34. PMID 17666740 DOI: 10.1007/978-1-59745-223-6_2  0.328
2007 Peter C, Kielstein JT, Clarke-Katzenberg R, Adams MC, Pitsiouni M, Kambham N, Karimi MA, Kengatharan KM, Cooke JP. A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization. The Journal of Urology. 177: 2342-6. PMID 17509355 DOI: 10.1016/J.Juro.2007.01.117  0.423
2007 Abrahamsson A, Geron I, Gotlib J, Dao K, Giles F, Newton I, Kavalerchik E, Durocher J, Creusot R, Karimi M, Jones C, Zehnder J, Keating A, Negrin R, Weissman IL, et al. Missplicing of Glycogen Synthase Kinase 3β: A Potential Mechanism of Blast Crisis Chronic Myeloid Leukemia Stem Cell Generation. Blood. 110: 775-775. DOI: 10.1182/Blood.V110.11.775.775  0.325
2006 Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Schulz S, Thorne SH, Teng NN, Contag CH, Lum LG, Negrin RS. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1859-67. PMID 16551871 DOI: 10.1158/1078-0432.Ccr-05-2019  0.511
2006 Anderson EM, Hamilton CA, Chan JK, Karimi M, Baker J, Husain A, Teng NN, Negrin RS. 139 Bispecific Antibody-Redirected Immunotherapy of Her2/neu-expressing Uterine Cancer. Journal of Investigative Medicine. 54. DOI: 10.2310/6650.2005.X0004.138  0.503
2006 Karimi M, Su L, Chan J, Negrin R. F.122. Deletion in H-NKG2D Ligand Effects Tumors Resistance to T-Cells Mediated Cytotoxicity Clinical Immunology. 119. DOI: 10.1016/J.Clim.2006.04.162  0.362
2005 Karimi M, Cao TM, Baker JA, Verneris MR, Soares L, Negrin RS. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells. Journal of Immunology. 175: 7819-7828. PMID 16339517 DOI: 10.4049/Jimmunol.175.12.7819  0.545
2005 Verneris MR, Arshi A, Edinger M, Kornacker M, Natkunam Y, Karimi M, Karami M, Cao YA, Marina N, Contag CH, Negrin RS. Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4561-70. PMID 15958642 DOI: 10.1158/1078-0432.Ccr-05-0157  0.377
2005 Jamieson C, Karimi M, Creusot R, Negrin R, Gotlib J, Chao M, Jones C, Keating A, Fathman CG, Zehnder J, Weissman IL. Bioluminescent Imaging of Human Leukemic Stem Cell Engraftment. Blood. 106: 696-696. DOI: 10.1182/Blood.V106.11.696.696  0.409
2005 Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Lum LG, Schulz S, Thorne SH, Teng NN, Contag CH, Negrin RS. Immunotherapy of Primary Ovarian Cancer Using Autologous Cytokine Induced Killer Cells Retargeted with Bispecific Antibodies: A Preclinical Study. Blood. 106: 2379-2379. DOI: 10.1182/Blood.V106.11.2379.2379  0.528
2005 Zeiser R, Nguyen V, Buess M, Karimi M, Bjorck P, Baker J, Negrin RS. Prevention of Acute Graft-Versus-Host Disease by CD4+CD25+ Regulatory T Cells Is Dependent on the CD30/CD153 Pathway. Blood. 106: 1299-1299. DOI: 10.1182/Blood.V106.11.1299.1299  0.443
2005 Jamieson C, Karimi M, Creusot R, Fathman C, Negrin R, Weissman I. Bioluminescent tracking of candidate leukemic stem cell engraftment in immunocompromised mice Biology of Blood and Marrow Transplantation. 11: 86. DOI: 10.1016/J.Bbmt.2004.12.254  0.334
2005 Karimi MA, Cao T, Soares L, Negrini RS. Inhibitory effects of cytotoxicity of cytokine activated and expanded human CD8+ T cells by a human NKG2D alternative splice variant Biology of Blood and Marrow Transplantation. 11: 8. DOI: 10.1016/J.Bbmt.2004.12.023  0.464
2004 Karimi MA, Cao T, Verneris MR, Baker J, Negrin RS. Silensilencing Human NKG2D, DAP10 and DAP12 Reduces Cytotoxicity of in Vivo Activated CD8 + T and NK Cells. Blood. 104: 446-446. DOI: 10.1182/Blood.V104.11.446.446  0.568
2004 Karimi MA, Cao TM, Soares L, Negrin RS. Inhibitory Effects of Cytotoxicity of Cytokine Activated and Expanded Human CD8+ T Cells by a Human NKG2D Alternative Splice Variant. Blood. 104: 3243-3243. DOI: 10.1182/Blood.V104.11.3243.3243  0.542
2003 Verneris MR, Karimi M, Karami M, Baker J, Jayaswal A, Negrin RS. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. Blood. 103: 3065-72. PMID 15070686 DOI: 10.1182/BLOOD-2003-06-2125  0.484
Show low-probability matches.